Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Mechanisms Underlying Neurotypical and Disordered Speech

NCT07459803 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.

NCT NCT07459803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Mechanisms Underlying Neurotypical and Disordered Speech
Lead sponsor
Boston University Charles River Campus
Phase
Not applicable
Overall status
Recruiting
Start date
June 12, 2026
Completion date
March 31, 2030
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dyslexia, healthy participants, stuttering, developmental